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Background: Central fever (CF) is defined as elevated temperature with no identifiable cause. We aimed to identify
risk factors for developing CF among patients with spontaneous intracerebral hemorrhage (ICH) and to evaluate the
impact of CF on outcome.
Methods: Patients included in our prospective stroke registry between 1/1/09 and 1/10/10 were studied. We
identified patients with CF as those with a temperature ≥38.3°C without evidence for infection or drug fever.
Patients with CF were compared to those without fever and those with infectious fever. Demographics, risk factors
and imaging data as well as outcome parameters were reviewed.
Results: We identified 95 patients with spontaneous ICH (median age 76, median admission NIHSS 9). CF was
identified in 30 patients (32%), infectious etiology was found in 9 patients (9%) and the remaining patients did not
develop fever. Baseline variables were similar between the groups except for intra-ventricular extension of the ICH
(IVH) and larger ICH volumes that were more common in the CF group (OR = 4.667, 95% CI 1.658-13.135 and OR =
1.013/ml, 95% CI 1.004-1.021). Outcome analysis showed higher mortality rates (80% vs. 36%, p < 0.001) and lower
rates of favorable functional outcome defined as a modified Rankin score ≤ 2 at 90 days (0% vs. 53%, p < 0.001) in
the CF group.
Conclusions: The risk of CF is increased in patients with larger ICH and in those with IVH. CF negatively impacts
outcome in patients with ICH.
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Intra-cerebral hemorrhage (ICH) is the most common
non-ischemic cause of stroke [1,2] and is associated with
very high morbidity and mortality rates [3-5].
The low survival rates of patients who suffer from
ICH emphasize the importance of identifying prognostic
factors. Previous research suggests that prognosis after
ICH depends on hematoma location and size, neurological
disability and level of consciousness at presentation,
age, comorbidities, preceding anti-coagulant therapy
and hyperthermia [3,4,6-10].* Correspondence: asafh@hadassah.org.il
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unless otherwise stated.Hyperthermia was found to have deleterious effects on
outcome in experimental models of brain injury [11-13].
Similar deleterious effects on outcome were found in
patients with either ischemic or hemorrhagic stroke
[14-18]. Moreover, brain temperature elevations have
been associated with elevated intracranial pressure after
subarachnoid hemorrhage (SAH) and traumatic brain
injury (TBI) in the absence of infection [19].
Central fever (CF) was initially described as a rapid in-
crease in core body temperature and icy cold extrem-
ities in the immediate aftermath of brain surgery [20].
Commichau et al. [21] found that fever (defined as
temperature > 38.3°C) was observed in 23% of neuro-
logical intensive care unit (NICU) patients. Among
them, 42% were associated with an identified infection
but in 28% no explanation for the increased temperatureThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Honig et al. BMC Neurology  (2015) 15:6 Page 2 of 7could be identified suggesting a central origin of the fever.
It is hypothesized that damage to any of the structures
involved in temperature homeostasis pathways includ-
ing coetaneous thermal receptors, spinal cord, midbrain
and hypothalamus may cause CF [22-24]. Indeed,
several studies have shown correlations between lesion
size, type and location and the development of fever after
brain injury [25-27].
The current study attempted to examine whether CF
is associated with spontaneous ICH, whether factors pre-
dicting the development of CF can be identified and
whether CF influences outcome in patients with ICH.
Methods
We prospectively recruited consecutive patients pre-
senting with ICH into our stroke registry. The institu-
tional review board (Hadassah Medical Organization)
authorized anonymous inclusion of patients into the
consecutive data base without getting informed consent
(approval # HMO-09-0277).
In the current analysis we included patients with ICH
admitted between 1.1.2009 and 1.10.2010. The diagnosis
of ICH was established according to clinical findings
and a baseline non-contrast CT scan that showed the
hemorrhage.
We studied demographics and cerebrovascular risk
profile. Patients had a follow up non-contrast CT at
24 hours from treatment. According to this follow up
CT, location and volume of hematoma, presence of sub-
arachnoid or intraventricular hemorrhage were accrued.
The volume of the hematoma was assessed with the
ABC/2 formula [28]. In every case of atypical presenta-
tion of ICH further radiologic evaluation using CT angi-
ography, angiography and MR imaging were performed.
Every case of ICH that resulted from an etiology other
than spontaneous ICH was excluded from the study.
Another measure taken to ascertain this was a follow up
MRI performed on 16 patients after full hematoma reso-
lution and failed to reveal any underlying structural
etiology.
Neurological severity at presentation was measured
with the National Institutes of Health Stroke Scale
(NIHSS) [26].
All patients were treated in an intensive care unit for
at least 24 hours. Temperature data was collected for
the first week after admission. Only patients with full
data sets of temperature during the first week of admis-
sion were included in the study. Body temperature was
measured at least three times daily. Only three daily
measurements were performed in patients without fever.
In each case with fever measured and especially in cases
with antipyretics treatment a much more frequent
protocol of temperature measurement was introduced.
Temperature measurements were taken orally whenpatients were fully alert and rectally upon reduced con-
sciousness. In any case of fever detected orally, temperature
was taken three times at the ear to assure the measurement
accuracy. As the ear site quickly responds to changes in the
set point temperature, it is a preferable and recommendable
site for measurement of body temperature [29]. As the
difference between ear and rectal measurements is of
less than 0.2-0.3°C, we did not expect it to change the
results of the study [29]. Due to the deleterious effect of
fever on patients in the setting of acute ICH, every pa-
tient with fever above 38.3°C was treated promptly with
a variety of temperature lowering agents. In such a case,
temperature measurements were taken an hour later to
ensure temperature control. In unconscious patients
with fever above 40°C we have used ice water baths and
cold saline infusions. In accordance with previous stud-
ies on central fever [21,30], presence of fever was de-
fined as any temperature measurement ≥38.3°C. Time
elapsed from symptom onset to temperature elevation,
peak temperature measurement and time elapsed to
peak temperature were collected during the first week
of hospitalization. All hyperthermic patients underwent
serial chest x-rays, blood counts and repeated cultures
of blood, urine, respiratory secretions, stool and shunt
fluid if applicable. All patients also had PCR for Clos-
tridium in order to identify infectious causes.
Strict anti-infectious measures are taken on a perman-
ent basis in our neurological ICU. These strict measures
include frequent hand wash by the healthcare personnel
in general including and during procedures in particular.
Intravenous line catheters are replaced on a regular basis
according to a standardized internal protocol. In order
to avoid microaspirations leading to aspiration pneumo-
nia, every patient who develops dysphagia is inserted
with a nasogastric tube without delay. Respiratory ma-
chines and equipment are being closely monitored in
every patient by a special team. Regarding catheter asso-
ciated urinary tract infection (CAUTI), duration of cath-
eter insertion and unnecessary repositioning has been
minimized as much as possible in order to prevent bac-
teriuria and potential infection.
For the purposes of the current study the patients
were divided into 3 groups: a. Infectious Fever (InF) -
defined as any fever measurement ≥ 38.3°C with clinical
and a clear laboratory or radiological evidence of infection.
Hence, only patients with a positive chest X ray or a posi-
tive laboratory as bacterial culture growth or a positive
PCR were regarded as InF b. Central Fever (CF) – defined
as peak fever measurement ≥ 38.3°C without evidence of
infection. c. No Fever (NoF) – defined as no fever mea-
surements ≥ 38.3°C during the first week of admission.
Patients with alternative identified causes of noninfec-
tious fever such as drug fever, venous thromboem-
bolism and blood transfusion reactions were excluded.
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chosen by Commichau et al. [21] for the purpose of
comparison to our study.
All data included in our stroke registry is used for
quality control assurance and functional deficits before
admission and at 90 days post infarct were evaluated
with the modified Rankin Scale (mRS) score as part of
our standard protocol. Favorable outcome was defined
as a mRS ≤ 2.
Statistical evaluations were performed with the SPSS
PASW 18 package (IBM USA). Data was compared
using student’s t-test for continuous variables or chi
square tests for categorical variables. mRS data was
dichotomized into 0–2 or >3. Regression analysis con-
trolling for variables that yielded a p value of <0.1 on
the univariate analysis, was used to determine factors
associated with outcome. The Kaplan-Meier Survival
analysis with the log-rank test was applied for assessing
the effect of a single, categorical variable on survival.
Assessment of several variables (categorical & numerical)
on survival was carried out using the Cox-Regression
model. In this model the Adjusted Hazard Rate (HR) with
its 95% Confidence interval was calculated. All statistical
tests applied were two-tailed, and p < 0.05 was considered
statistically significant.
Results
Out of 141 patients admitted for ICH during the study
period, 95 patients had spontaneous ICH and full data
sets and therefore included in the study. Excluded
patients had traumatic ICH (8), ischemic stroke with
hemorrhagic transformation (16), tumor (4) or incom-
plete data sets (18).
Of the included 95 patients with full data sets, 39
(41%) had at least one episode of fever (≥38.3°C) during
the first week of hospitalization. Of those, 9 had evi-
dence for infection and were classified as InF (9%) while
the remaining 30 were classified as CF (32%).
In selected patients (n = 30) CT angiography and CT
venography were added to NCCT. When needed, a dedi-
cated angiogram was further performed to rule out
vascular malformations (n = 3). Patients with confirmed
secondary ICH (e.g. tumors or malformations etc.) were
excluded (n = 5) from the study. Furthermore, since the
hematoma can obscure underlying structural etiologies
and in order to make an accurate diagnosis, a follow up
MRI was performed on 16 patients. In one of these
patients, in an MRI imaging performed a year after the
ICH and after a full absorption of the hematoma, a small
underlying Cavernoma was found. This patient was ex-
cluded from the statistical analysis.
The presumed etiology of the ICH varied. Hypertension
was present in 73 of the patients. Sixteen patients were
treated with anticoagulants and 5 of these patients werealso taking antiplatelet medications. Of the remaining pa-
tients, 39 were treated with a single antiplatelet. Thirty
two patients had lobar ICH. In five patients a follow up
MRI was performed and in four of them typical radio-
logical features of cerebral amyloid angiopathy were seen.
The baseline characteristics of included patients are
presented in Table 1. The median age was 76.5 (range
34–98) and 44% were females. The median hemorrhage
volume was 22.1 ml (range 0.5-277). The median admis-
sion NIHSS was 9 (range 0–24). The bleeding also
involved SAH and IVH components in 16.7% and 47.1%
of the patients respectively.
There were no differences in baseline characteristics
between the CF and NoF groups, while the InF and CF
groups differed only in that lower platelet counts were
noted in the InF group (p = 0.003, Table 1).
The median time from ICH onset to first fever recording
was 24 hours (range 0–120) and the median time for fever
peak was 48 hours (range 0–150). Correlation analysis
showed that fever peak was higher when the fever started
earlier (Pearson Correlation ([PC)] = −0.412, p = 0.009)
and this showed higher correlation when tested only on
CF group (PC = −0.519, p = 0.003).
The time to fever onset and time to peak temperatures
were not significantly different between CF and InF pa-
tients but peak temperatures were significantly higher in
the CF group (p = 0.035).
The only factors associated with CF in the univariate
analysis (Table 2) were the presence of IVH (70% in CF
vs. 30.4% in NoF, p < 0.001) and larger ICH volumes
(86.7 ± 66.5 ml in CF vs. 33.7 ± 54.4 ml in NoF, Figure 1
p < 0.001). There was no significant difference between
CF and InF in all other ICH attributes and the presence
of SAH and hematoma location were not associated
with increased chances for developing CF although
basal ganglia (BG) and thalamic involvement showed a
trend towards significance.
After entering these candidate variables into a stepwise
forward logistic regression model, IVH (adjusted OR =
4.667, 95% CI 1.658-13.135) and larger hematoma
volumes (adjusted OR = 1.013/ml, 95% CI 1.004-1.021)
were identified as significant independent risk factors
for developing CF.
Chi-Square analysis of dichotomized mRS data (0–2
versus 3–6) revealed that CF was associated with
unfavorable outcome in 100% of cases while NoF was
associated with unfavorable outcome in only 46.9% of
patients at 90 days post event (Figure 2; p < 0.001).
None of the patients in the InF group had favorable
outcomes at day 90 and outcome data of this group did
not differ from the CF group (Figure 2). Combining all
febrile groups into a single group yielded similar results
regarding outcome as those of each individual febrile
group.
Table 1 Baseline characteristics
Variable CF (n = 30) InF (n = 9) NoF (n = 56) P(CF vs. InF) P(CF vs. NoF)
Age (mean ± SD) 73.67 ± 13.64 75.78 ± 11.45 72.71 ± 12.02 0.676 0.739
Male (%) 40 66.7 57.1 0.159 0.13
Hypertension (%) 75.9 88.9 76.8 0.402 0.924
Beta blockers (%) 21.4 33.3 30.4 0.657 0.387
Ca channel blockers (%) 32.1 33.3 28.6 1 0.736
ACEi/ARB (%) 50 33.3 39.3 0.462 0.35
Diuretics (%) 21.4 11.1 8.9 0.656 0.168
Smoking (%) 20 0 17.3 0.56 0.762
Diabetes Mellitus (%) 29.6 22.2 33.9 1 0.153
Previous CVA (%) 25 11.1 14.3 0.649 0.227
Previous ICH (%) 7.1 11.1 3.6 1 0.598
Antiplatelet treatment (%) 57.1 33.3 50 0.269 0.537
Anti-Coagulation (%) 10.3 22.2 14.3 0.574 0.742
INR (mean ± SD) 1.2 ± 0.583 1.48 ± 0.837 1.41 ± 1.255 0.27 0.404
PTT (mean ± SD) 26.79 ± 5.12 30.55 ± 9.91 29.33 ± 8.09 0.302 0.138
Platelets count (mean ± SD) 232.3 ± 72.58 177.5 ± 31.04 231.57 ± 93.6 0.003 0.971
ACEi- Angiotensin Converting Enzyme inhibitors, ARB- Angiotensin Receptor Blockers.
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Increasing temperatures were associated with higher
mortality rates (mean fever peak for survivors 38.5°C
and 39°C for deceased, p = 0.035). Mortality rates were
significantly higher among CF patients compared to
those without fever (80% CF vs. 29.1% respectively;
p < 0.001). After entering the presence of CF, hematoma
volumes and presence of IVH into forward stepwise
Cox-Regression analysis, CF (HR = 3.258, 95% CI 1.67-
6.37) and ICH volume (HR = 1.01/ml, 95% CI 1.007-
1.013) were identified as significant independent risk
factors for mortality. The Cox regression model was
also used to assess the effect of CF on lifespan. Again,
after entering the presence of CF, hematoma volumes
and presence of IVH into forward stepwise Cox-
Regression analysis for lifespan, CF (HR = 3.021, 95%
CI 1.49-6.85) and ICH volume (HR = 1.01/ml, 95% CI
1.005-1.013) were identified as significant independentTable 2 ICH characteristics
Variable CF (n = 30) InF (n = 9)
Any lobar involvement (%) 63.3 66.7
Any BG involvement (%) 76.7 77.8
Any thalamic involvement (%) 43.3 22.2
Any Cerebellar involvement (%) 3.3 0
Any BS involvement (%) 6.7 11.1
Volume (mean ± SD) [ml] 86.7 ± 66.5 67.7 ± 67.4
IVH (%) 70 55.6
SAH (%) 23.3 11.1
BG – Basal ganglia, BS- Brainstem, IVH – Intraventricular hemorrhage, SAH – Subararisk factors for a shorter lifespan. Life span analysis
using Kaplan-Meir survival curves (Figure 3) demon-
strated significantly higher mortality rates among CF
patients compared with NoF (mean projected lifespan:
315 days for CF and 1100 days for NoF, p < 0.001). No
significant difference in mortality was found between
CF and InF.
Discussion
The main findings of the current study are that 30% of
patients suffering from ICH developed CF [17,21] and
that CF is associated with poor outcome and increased
mortality rates in these patients.
The current results are in agreement with previous
studies that identified the presence of IVH and increasing
ICH volume as predictors of CF in patients with SAH and
ICH [17,21,26,30,31]. More recently, Rincon et al. [32] de-










Figure 1 Mean hemorrhage volumes. Bar graph showing the mean hemorrhage volumes in patients with infectious (InF), central (CF) and no
(NoF) fever groups.
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hematoma volume, intraventricular-hemorrhage, pneu-
monia, and hematoma growth as markers for develop-
ment of fever. Another study [25] included 282 patients
with ischemic infarcts and 48 patients with ICH. Fever
occurred in 37.6% of patients and 14.8% had fever with-
out a documented infection. In multivariate analysis,
age, Scandinavian Stroke Scale score and mass effect
were found to b significantly associated with fever. In a
logistic regression analysis, the only factor predictive of
CF versus infection was earlier onset of fever. These
findings were recently supported by Hocker et al. [30]
who found that CF is more likely to occur within 72
hours of admission to the neurologic ICU. However, the
specific impact of CF on outcome in ICH was studied
less often and most previous studies lumped ICU pa-
tients with fever into a single group.
Previous studies suggest that the association between
intraventricular involvement and CF may involve prosta-
glandin stimulation of the thermoregulatory pathways
[22-24] and especially the hypothalamus or direct com-
pression of thermo-sensitive neurons in the brain stem
or hypothalamus [27,33]. Interestingly, the current studyFigure 2 Outcome at 90 days post ICH. Bar graphs showing percentage offound no significant correlation between ICH location
and occurrence of CF although thalamic and basal gan-
glia involvement showed a trend towards being signifi-
cantly more common in patients with CF. This is not
surprising when taking into account the proximity of
these structures to the third ventricle and the increased
incidence of IVH occurrence with such hemorrhage
types. Therefore, it appears plausible that future studies
including larger numbers of patients may identify
hematoma locations such as the thalamus as a potential
risk factor for developing CF.
Importantly, peak fever was significantly higher in CF
patients compared with InF. In addition, correlation ana-
lysis revealed that the earlier the fever started the higher
the peak reached. These findings are in agreement with
the common notion that CF develops within the first
24 hours from brain injury and reaches high peaks of
40-42°C [20,25]. However, it also shows that a definition
based on the mentioned timeline is difficult to establish,
probably due to the spectrum of structural damage that
might lead to different levels of irritation in the thermo-
regulatory centers as well as to the presence of con-
founding variables such as infections or drug reactions.patients in each modified Rankin Scale category at 90 days after ICH.
Figure 3 Survival analysis. Kaplan Meyer survival curves comparing patients with central (CF) or no (NoF) fever.
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and unfavorable outcome rates between the CF and InF
groups and both groups fared worse than afebrile
patients. This may suggest that it is the actual presence of
fever that determines prognosis and not the actual cause of
the increased temperature. Indeed, hyperthermia is associ-
ated with poor outcome in many forms of experimental
and clinical brain injury [11,13,14,16,18,19]. The mecha-
nisms responsible for the poor outcome in hyperthermic
patients remain unknown but may include increased intra-
cranial pressure [19], reduced cerebral blood flow [19] and
increase in inflammatory cytokines and axonal death [12].
Our study has several potential limitations. First, the
numbers of included patients with InF was surprisingly
small and may have hampered full analysis of differ-
ences between the InF and CF groups [34]. However, we
believe that the paucity of infections detected in our
study stems from adopting strict anti-infectious strat-
egies in our intensive care unit as well as in our Neur-
ology department since similar and even lower rates of
infection were observed for patients with ischemic
stroke. Second, this was a retrospective analysis of the
data rather than a prospective randomized study and
this may have introduced a bias. However, the data was
accrued prospectively which may limit the bias effect.
Third, we did not evaluate potential treatments for CF
or InF and treatment effects on outcome. We believe
that given the relatively high frequency and the large
observed impact of CF on outcome, these parameters
should be the subject of future randomized studies.
While previous studies have either focused on ICU pa-
tients in general or on stroke patients combining both
ischemia, ICH, subdural and Subarachnoid hemorrhage
(SAH), our study specifically focused on patients with
primary spontaneous ICH. Our results are in agreement
with previous studies in finding the presence of IVH and
increasing ICH volume as predictors of CF in patients
with SAH and ICH.Previously it was believed that CF develops within the
first 24 hours from brain injury and reaches a peak of
40-42°C [20,25]. Our findings are in partial agreement
with these findings. In regard to temperature, our study
showed that peak fever was significantly higher in CF
patients compared with InF and correlation analysis
revealed that the earlier the fever started the higher the
peak reached. In regard to the timeframe of CF, our find-
ings were much like those of Hocker et al. who found
that CF is more likely to occur within 72 hours of
admission to the neurologic ICU but can also occur later
on. We presume that a definition based on the men-
tioned timeline is difficult to establish, probably due to
the spectrum of structural damage that might lead
to different levels of irritation in the thermoregulatory
centers.
Conclusion
In conclusion, CF is common after spontaneous ICH and
the risk of developing CF is increased in patients with
larger ICH and in those with IVH extension. CF is associ-
ated with increased mortality rates, shorter lifespan and
with reduced chances for favorable outcome and should
be considered as a poor prognostic factor in patients with
ICH. Future studies are needed to evaluate treatments
for CF in an effort to minimize ICH induced damage and
poor outcome.
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